At age 62, the patient was found to have low serum IgG (572 mg/dL) and IgM (28 mg/dL) levels, as well as impaired response to Pneumovax, which prompted the initiation of IgG replacement therapy (IgGRT) that markedly diminished the frequency and severity of her recurrent infections. This evidence concerns the gene CD40LG and infection.